Skip to content

Drug interactions

Empagliflozin-linagliptin + Somatropin

Severity: Moderate

Empagliflozin-linagliptin and Somatropin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Growth hormone reduces insulin sensitivity and can raise blood glucose, particularly at higher doses. This may weaken the glycemic control achieved with empagliflozin and linagliptin.

What this interaction means in plain words

Empagliflozin-linagliptin and Somatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Empagliflozin-linagliptin belongs to Endocrine; Somatropin belongs to Endocrine.

Evidence level: Moderate

Why it happens

Pharmacodynamic antagonism: growth hormone induces insulin resistance and counteracts the effect of antidiabetic agents.

What to do

Monitor blood glucose and HbA1c after starting or changing the somatropin dose, and adjust antidiabetic therapy as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Somatropin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin-linagliptin with Somatropin?

MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Somatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Growth hormone reduces insulin sensitivity and can raise blood glucose, particularly at higher doses. This may weaken the glycemic control achieved with empagliflozin and linagliptin.

How serious is the interaction between Empagliflozin-linagliptin and Somatropin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c after starting or changing the somatropin dose, and adjust antidiabetic therapy as needed.

What other medicines interact with Empagliflozin-linagliptin?

MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in